Literature DB >> 10788489

Initiation of human DNA replication in vitro using nuclei from cells arrested at an initiation-competent state.

T Krude1.   

Abstract

Initiation of human DNA replication is investigated in vitro, using initiation-competent nuclei isolated from cells arrested in late G(1) phase by a 24-h treatment with 0.5 mm mimosine (Krude, T. (1999) Exp. Cell Res. 247, 148-159). Nuclei isolated from mimosine-arrested HeLa cells initiate semiconservative DNA replication upon incubation in cytosolic extracts from proliferating human cells. Initiation occurs in the absence and presence of a nuclear membrane. The cyclin-dependent kinase (Cdk) inhibitors roscovitine and olomoucine inhibit initiation of DNA replication, indicating a dependence of initiation on Cdk activity. Cell fractionation shows that cyclins A, E, and Cdk2 are bound to nuclei from mimosine-arrested cells. Exogenously added human cyclin A.Cdk2 and cyclin E.Cdk2 complexes, but not cyclin B1/Cdk1 or cyclin D2/Cdk6, can overcome inhibition of initiation by roscovitine in vitro. Depleting Cdk2 from cytosolic extract does not prevent initiation, demonstrating that cyclin.Cdk2 complexes are not required in the soluble extract, but are provided by the nuclei. Initiation depends further on an essential and soluble activity present in cytosolic extracts from proliferating cells, but not from mimosine-arrested cells, acting together with nuclear cyclin/Cdk2 activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788489     DOI: 10.1074/jbc.275.18.13699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Site-specific and temporally controlled initiation of DNA replication in a human cell-free system.

Authors:  Christian Keller; Olivier Hyrien; Rolf Knippers; Torsten Krude
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  RPA is an initiation factor for human chromosomal DNA replication.

Authors:  Dávid Szüts; Lisa Kitching; Christo Christov; Aidan Budd; Sew Peak-Chew; Torsten Krude
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

3.  The Croonian Lecture 2001 hunting the antisocial cancer cell: MCM proteins and their exploitation.

Authors:  Ronald Laskey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-06-29       Impact factor: 6.237

4.  Functional requirement of noncoding Y RNAs for human chromosomal DNA replication.

Authors:  Christo P Christov; Timothy J Gardiner; Dávid Szüts; Torsten Krude
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  Centrosome duplication proceeds during mimosine-induced G1 cell cycle arrest.

Authors:  Thomas M Durcan; Elizabeth S Halpin; Luciana Casaletti; Kevin T Vaughan; Maggie R Pierson; Shane Woods; Edward H Hinchcliffe
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

Review 6.  Cell cycle regulation of DNA replication.

Authors:  R A Sclafani; T M Holzen
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

Review 7.  The human intra-S checkpoint response to UVC-induced DNA damage.

Authors:  William K Kaufmann
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

8.  c-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation.

Authors:  Anup Kumar Singh; Manickavinayaham Swarnalatha; Vijay Kumar
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

9.  Dynamic interaction of Y RNAs with chromatin and initiation proteins during human DNA replication.

Authors:  Alice Tianbu Zhang; Alexander R Langley; Christo P Christov; Eyemen Kheir; Thomas Shafee; Timothy J Gardiner; Torsten Krude
Journal:  J Cell Sci       Date:  2011-05-24       Impact factor: 5.285

10.  Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.

Authors:  Yuehua Huang; Shuping Tong; Andrew W Tai; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.